搜尋
Procept Biorobotics Corp
PRCT添加自選
18.620USD
+0.620+3.44%
收盤 07-31 16:00（美東）報價延遲15分鐘
1.06B總市值
虧損本益比TTM
關於 Procept Biorobotics Corp 公司
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.
Procept Biorobotics Corp簡介
公司代碼PRCT
公司名稱Procept Biorobotics Corp
上市日期Sep 15, 2021
CEOWood (Larry L)
員工數量756
證券類型Ordinary Share
年結日Sep 15
公司地址150 Baytech Drive
城市SAN JOSE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編95134
電話16502329832
網址https://www.procept-biorobotics.com/
公司代碼PRCT
上市日期Sep 15, 2021
CEOWood (Larry L)
Procept Biorobotics Corp公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
864.94K
+0.38%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
136.03K
+2.44%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
79.32K
-0.45%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
16.16K
+20.51%
Ms. Elisabeth Little
Ms. Elisabeth Little
Independent Director
Independent Director
11.02K
--
Thomas M. Prescott
Thomas M. Prescott
Independent Chairman of the Board
Independent Chairman of the Board
4.10K
+80.83%
Mr. Larry L. Wood
Mr. Larry L. Wood
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.20K
-9770.22%
Ms. Amy M. Dodrill
Ms. Amy M. Dodrill
Independent Director
Independent Director
--
--
Mr. Antal Desai
Mr. Antal Desai
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
864.94K
+0.38%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
136.03K
+2.44%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
79.32K
-0.45%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
16.16K
+20.51%
Ms. Elisabeth Little
Ms. Elisabeth Little
Independent Director
Independent Director
11.02K
--
常見問題
Procept Biorobotics Corp的前五大股東是誰？
Procept Biorobotics Corp的前五大股東如下：Dr. Frederic H. (Fred) Moll, M.D.
有多少機構持有Procept Biorobotics Corp(PRCT)的股份？
截至2026Q1，共有597家機構持有Procept Biorobotics Corp的股份，合計持有的股份價值約為65.01M，占公司總股份的114.22% 。與2025Q4相比，機構持股有所增加，增幅為-1014187.00。
哪個業務部門對Procept Biorobotics Corp的收入貢獻最大？
在2026Q1，Hand pieces and other consumables業務部門對Procept Biorobotics Corp的收入貢獻最大，創收181.45M，占總收入的58.90% 。